Drugs / mammalian Omega 3 Fatty acids
mammalian Omega 3 Fatty acids
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02294149 | Jan → Apr 2015 | cancer, peripheral neuropathy | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mammalian Omega 3 Fatty acids | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02294149 ↗ |
| Modality | Other / unclassified | “A mammalian oil derived Omega 3 FA that is a further concentrated and purified supplement as compared to the regular fish oil derived Omega 3 FA supplement.” NCT02294149 ↗ |
| Route | Other | “Sub-lingual Omega 3 FA and Vitamin D3 supplements for 6 months, twice daily ,1/2 tea spoon with instructions to keep it under the tongue for 45 sec.” NCT02294149 ↗ |